Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does Glucagon-like Peptide (GLP-1) Receptor Agonist Stimulation Reduce Alcohol Intake in Patients With Alcohol Dependence?

NCT03232112 is registered in ClinicalTrials.gov with Anders Fink-Jensen, MD, DMSci as lead sponsor.

NCT NCT03232112
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03232112 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does Glucagon-like Peptide (GLP-1) Receptor Agonist Stimulation Reduce Alcohol Intake in Patients With Alcohol Dependence?
Lead sponsor
Anders Fink-Jensen, MD, DMSci
Phase
Phase 2
Overall status
Completed
Start date
August 7, 2017
Completion date
October 5, 2020
Enrollment
152 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

addiction, alcohol, alcohol dependence, in remission